𝔖 Bobbio Scriptorium
✦   LIBER   ✦

325Antisense-mediated telomerase inhibition sensitizes human bladder cancer cell lines to chemotherapeutic drugs

✍ Scribed by K. Kraemer; S. Fuessel; U. Schmidt; A. Meye; M.P. Wirth

Book ID
118646457
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
180 KB
Volume
4
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Drug-resistant human bladder-cancer cell
Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells
✍ Toshiro Shirakawa; Ryohei Sasaki; Thomas A. Gardner; Chinghai Kao; Zhu-Jun Zhang πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 373 KB

We investigated the therapeutic potential and molecular mechanism of adenovirus-mediated wt p53 gene therapy for drug-resistant human bladder cancers. KK47, a human bladder-cancer cell line, along with the drug-resistant sublines KK47/DDP10, KK47/DDP20 (cisplatin-resistant) and KK47/ ADM (doxorubici

In vitro response of human small-cell lu
In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data
✍ E. F. Smit; E. G. E. de Vries; H. Timmer-Bosscha; L. F. H. M. de Leij; J. W. Oos πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 French βš– 844 KB

Three cell lines derived from small-cell lung carcinoma (SCLC) tumors of patients who had no clinical response after treatment with a multi-drug regimen were compared to 3 cell lines derived from tumors of patients who, upon treatment, showed a complete clinical response. These 2 groups of cell line

Inhibition of farnesyl protein transfera
Inhibition of farnesyl protein transferase sensitizes human MCF-7 breast cancer cells to roscovitine-mediated cell cycle arrest
✍ JΓ³zefa WΔ™sierska-GΔ…dek; Margarita Maurer; Gerald Schmid πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 253 KB πŸ‘ 1 views

## Abstract We reported recently that roscovitine (ROSC), a selective cyclin‐dependent kinase (CDK) inhibitor, arrests human MCF‐7 breast cancer cells in G~2~ phase of the cell cycle, and concomitantly induces apoptosis. Human MCF‐7 breast cancer cells are known to express elevated levels of c‐Ha‐R